Hamlet Pharma AB
Records under this name other than the patents Hamlet Pharma AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 7 of 7 · Back to Hamlet Pharma AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,270,822 | Active complex of alpha-lactalbumin (hamlet) and cofactor Term ended Term ended Jun 24, 2023 · From the USPTO record | Term ended | Term ended Jun 24, 2023 | From the USPTO record |
| US 7,713,533 | Active complex of α-lactalbumin (HAMLET) and cofactor Term ended Term ended May 26, 2023 · From the USPTO record | Term ended | Term ended May 26, 2023 | From the USPTO record |
| US 7,524,932 | Lactalbumin production process Term ended Term ended Jan 29, 2020 · From the USPTO record | Term ended | Term ended Jan 29, 2020 | From the USPTO record |
| US 7,053,185 | Lactalbumin production process Lapsed on the fee record Ended May 30, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 30, 2018 | From the USPTO record |
| US 7,144,855 | Protein complex from ion-exchange chromatography for treatment of bacterial infections Formerly held Lapsed on the fee record Ended Dec 5, 2014 · From the USPTO record | Lapsed on the fee record | Ended Dec 5, 2014 | From the USPTO record |
| US 6,599,874 | Protein complex from ion-exchange chromatography of casein for treatment of bacterial infections Formerly held Term ended Term ended Aug 16, 2014 · From the USPTO record | Term ended | Term ended Aug 16, 2014 | From the USPTO record |
| US 6,808,930 | Therapeutic agents Formerly held Lapsed on the fee record Ended Oct 26, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 26, 2012 | From the USPTO record |